The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Dalgleish, Angus George
    Professor Of Oncology, London born in May 1950
    Individual (7 offsprings)
    Officer
    2015-04-21 ~ now
    OF - Director → CIF 0
  • 2
    Mitchell, Michael Dennis, Henry
    Company Director born in May 1950
    Individual (2 offsprings)
    Officer
    2015-05-07 ~ now
    OF - Director → CIF 0
  • 3
    Thompson, Ian
    Consultant/Advisor born in April 1981
    Individual (4 offsprings)
    Officer
    2015-02-17 ~ now
    OF - Director → CIF 0
    Mr Ian Thompson
    Born in April 1981
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 4
    Sweeney, Paul Joseph
    Consultant/Advisor born in June 1968
    Individual (1 offspring)
    Officer
    2015-02-17 ~ now
    OF - Director → CIF 0
    Mr Paul Joseph Sweeney
    Born in June 1968
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 5
    Burton, Graham Henry
    Consultant born in September 1950
    Individual (2 offsprings)
    Officer
    2015-07-15 ~ now
    OF - Director → CIF 0
Ceased 2
  • 1
    Gordon, Michael Thomas
    Director born in March 1954
    Individual (193 offsprings)
    Officer
    2015-01-22 ~ 2015-02-17
    OF - Director → CIF 0
  • 2
    5 Jupiter House, Calleva Park, Aldermaston, Reading, Berkshire, United Kingdom
    Dissolved Corporate (3 parents, 155 offsprings)
    Officer
    2015-01-22 ~ 2015-02-17
    PE - Director → CIF 0
parent relation
Company in focus

LDN PHARMA LIMITED

Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
86900 - Other Human Health Activities
Brief company account
Called-up share capital (not paid)
0 GBP2023-06-30
0 GBP2022-06-30
Intangible Assets
5,001,621 GBP2023-06-30
4,607,950 GBP2022-06-30
Property, Plant & Equipment
0 GBP2023-06-30
0 GBP2022-06-30
Fixed Assets - Investments
0 GBP2023-06-30
0 GBP2022-06-30
Fixed Assets
5,001,621 GBP2023-06-30
4,607,950 GBP2022-06-30
Total Inventories
0 GBP2023-06-30
0 GBP2022-06-30
Debtors
71,341 GBP2023-06-30
51,567 GBP2022-06-30
Cash at bank and in hand
50,877 GBP2023-06-30
7,047 GBP2022-06-30
Current assets - Investments
0 GBP2023-06-30
0 GBP2022-06-30
Current Assets
122,218 GBP2023-06-30
58,614 GBP2022-06-30
Creditors
Amounts falling due within one year
-138,487 GBP2023-06-30
-58,669 GBP2022-06-30
Net Current Assets/Liabilities
-16,269 GBP2023-06-30
-55 GBP2022-06-30
Total Assets Less Current Liabilities
4,985,352 GBP2023-06-30
4,607,895 GBP2022-06-30
Creditors
Amounts falling due after one year
-366,710 GBP2023-06-30
-416,710 GBP2022-06-30
Net Assets/Liabilities
4,618,642 GBP2023-06-30
4,191,185 GBP2022-06-30
Equity
Called up share capital
24,686 GBP2023-06-30
24,624 GBP2022-06-30
Share premium
4,864,773 GBP2023-06-30
4,464,771 GBP2022-06-30
Revaluation reserve
0 GBP2023-06-30
0 GBP2022-06-30
Retained earnings (accumulated losses)
-270,817 GBP2023-06-30
-298,210 GBP2022-06-30
Equity
4,618,642 GBP2023-06-30
4,191,185 GBP2022-06-30
Average Number of Employees
02022-07-01 ~ 2023-06-30
02021-07-01 ~ 2022-06-30
Intangible Assets - Gross Cost
5,001,621 GBP2023-06-30
4,607,950 GBP2022-06-30
Intangible assets - Disposals
0 GBP2022-07-01 ~ 2023-06-30
Intangible Assets - Accumulated Amortisation & Impairment
0 GBP2023-06-30
0 GBP2022-06-30
Intangible Assets - Increase From Amortisation Charge for Year
0 GBP2022-07-01 ~ 2023-06-30
Intangible assets - Disposals and decrease in the amortization or impairment
0 GBP2022-07-01 ~ 2023-06-30
Debtors
Amounts falling due after one year
71,341 GBP2023-06-30
51,567 GBP2022-06-30

  • LDN PHARMA LIMITED
    Info
    Registered number 09400979
    45 Gresham Street, London EC2V 7BG
    Private Limited Company incorporated on 2015-01-22 (10 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-31
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.